Caseware UK (AP4) 2023.0.135 2023.0.135 2024-06-302024-06-30The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2023-07-01falseNo description of principal activity86truetrue 09995894 2023-07-01 2024-06-30 09995894 2022-07-01 2023-06-30 09995894 2024-06-30 09995894 2023-06-30 09995894 c:Director4 2023-07-01 2024-06-30 09995894 d:Buildings 2023-07-01 2024-06-30 09995894 d:Buildings 2024-06-30 09995894 d:Buildings 2023-06-30 09995894 d:Buildings d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 09995894 d:MotorVehicles 2023-07-01 2024-06-30 09995894 d:MotorVehicles 2024-06-30 09995894 d:MotorVehicles 2023-06-30 09995894 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 09995894 d:FurnitureFittings 2023-07-01 2024-06-30 09995894 d:FurnitureFittings 2024-06-30 09995894 d:FurnitureFittings 2023-06-30 09995894 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 09995894 d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 09995894 d:Goodwill 2023-07-01 2024-06-30 09995894 d:Goodwill 2024-06-30 09995894 d:Goodwill 2023-06-30 09995894 d:OtherResidualIntangibleAssets 2023-07-01 2024-06-30 09995894 d:CurrentFinancialInstruments 2024-06-30 09995894 d:CurrentFinancialInstruments 2023-06-30 09995894 d:Non-currentFinancialInstruments 2024-06-30 09995894 d:Non-currentFinancialInstruments 2023-06-30 09995894 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 09995894 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 09995894 d:Non-currentFinancialInstruments d:AfterOneYear 2024-06-30 09995894 d:Non-currentFinancialInstruments d:AfterOneYear 2023-06-30 09995894 d:ShareCapital 2024-06-30 09995894 d:ShareCapital 2023-06-30 09995894 d:RetainedEarningsAccumulatedLosses 2024-06-30 09995894 d:RetainedEarningsAccumulatedLosses 2023-06-30 09995894 c:FRS102 2023-07-01 2024-06-30 09995894 c:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 09995894 c:FullAccounts 2023-07-01 2024-06-30 09995894 c:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 09995894 d:Goodwill d:OwnedIntangibleAssets 2023-07-01 2024-06-30 09995894 e:PoundSterling 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure

Registered number: 09995894










B&W UNITED HEALTHCARE LTD








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2024

 
B&W UNITED HEALTHCARE LTD
REGISTERED NUMBER: 09995894

STATEMENT OF FINANCIAL POSITION
AS AT 30 JUNE 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 3 
181,843
218,211

Tangible assets
 4 
233,309
226,013

  
415,152
444,224

Current assets
  

Stocks
  
43,738
44,163

Debtors: amounts falling due within one year
 5 
98,602
89,832

Cash at bank and in hand
  
87,502
139,012

  
229,842
273,007

Creditors: amounts falling due within one year
 6 
(162,622)
(198,459)

Net current assets
  
 
 
67,220
 
 
74,548

Total assets less current liabilities
  
482,372
518,772

Creditors: amounts falling due after more than one year
 7 
(480,680)
(514,770)

Provisions for liabilities
  

Deferred tax
  
(801)
(1,068)

  
 
 
(801)
 
 
(1,068)

Net assets
  
891
2,934


Capital and reserves
  

Called up share capital 
  
400
400

Profit and loss account
  
491
2,534

  
891
2,934


Page 1

 
B&W UNITED HEALTHCARE LTD
REGISTERED NUMBER: 09995894
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 JUNE 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 4 March 2025.




Dr N M Patel
Director

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
B&W UNITED HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.


General information

B&W United Healthcare Limited is a private company, limited by share capital, incorporated in England and Wales under registration number 09995894. The address of the registered office is situated at Level 5A, Maple House, 149 Tottenham Court Road, London, W1T 7NF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
B&W UNITED HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.3

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Income statement over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Goodwill
-
20
years

The directors' of the company have changed the amortisation policy from 10 years to 20 years from 1 July 2023.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Freehold property
-
2%
straight line
Delivery van
-
25%
reducing balance
Fixtures and fittings
-
25%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
B&W UNITED HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.5

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

Page 5

 
B&W UNITED HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.10

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


Page 6

 
B&W UNITED HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

3.


Intangible assets




Goodwill

£



Cost


At 1 July 2023
727,370



At 30 June 2024

727,370



Amortisation


At 1 July 2023
509,159


Charge for the year on owned assets
36,368



At 30 June 2024

545,527



Net book value



At 30 June 2024
181,843



At 30 June 2023
218,211



Page 7

 
B&W UNITED HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

4.


Tangible fixed assets





Freehold property
Delivery van
Fixtures and fittings
Total

£
£
£
£



Cost or valuation


At 1 July 2023
227,993
2,650
9,427
240,070


Additions
-
-
17,680
17,680



At 30 June 2024

227,993
2,650
27,107
257,750



Depreciation


At 1 July 2023
7,600
2,296
4,161
14,057


Charge for the year on owned assets
4,560
88
5,736
10,384



At 30 June 2024

12,160
2,384
9,897
24,441



Net book value



At 30 June 2024
215,833
266
17,210
233,309



At 30 June 2023
220,393
354
5,266
226,013


5.


Debtors

2024
2023
£
£


Trade debtors
76,759
76,195

VAT repayable
7,998
11,749

Prepayments and accrued income
2,793
1,888

Directors' loan account
11,052
-

98,602
89,832


The balance on directors' loan account of Dr S B Kotecha was £3,705 debit balance (2023 - £127 credit balance), Mr N Shah was £3,684 debit balance (2023 - £34,042 credit balance) and Dr N M Patel was £3,663 debit balance (2023 - £119 credit balance) at 30 June 2024. Dr S B Kotecha paid £81 (2023 - £244), Mr N Shah paid £81 (2023 - £Nil) and Dr N M Patel paid £81 (2023 - £201) as interest to the company, calculated at the prevailing official HMRC rate of interest. 

Page 8

 
B&W UNITED HEALTHCARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
40,082
46,074

Trade creditors
95,243
104,758

Corporation tax
12,355
11,296

Other taxation and social security
1,838
1,427

Wages and Salaries
12,527
-

Pension payable
577
615

Directors' loan account
-
34,289

162,622
198,459


Bank loans are secured by a fixed and floating charge over the assets of the company.


7.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
480,680
514,770

480,680
514,770


Bank loans are secured by a fixed and floating charge over the assets of the company.


8.


Controlling party

There is no controlling party. 

Page 9